Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study

The study data-collection protocol is approved by the French National Commission for Informatics and Liberties, including approval from the <i>Comité Ethique et Scientifique pour les Recherches, les Etudes et les Evaluations dans le domaine de la Santé</i>. This study complies with French and European regulations, including those relating to the General Data Protection Regulation. This study uses pseudonymous information, not requiring informed consent. Dissemination plans include full publication of the study outcomes in peer-reviewed journal(s) with open access and presentations at national and international diabetes and cardiovascular conferences.

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-01-01
DOI
https://doi.org/10.1136/bmjopen-2024-085961
Citations
1
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
1.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study

Patrick Blin, Laure Carcaillon‐Bentata, Michaël Joubert, Tadej Battelino et al.
1 citations
BMJ Open
Diabetes Management and Research
1.29
article

Do continuous glucose monitoring (CGM) metrics predict macrovascular and microvascular complications in diabetes? The FACULTY protocol of a retrospective real-world cohort study

Patrick Blin, Laure Carcaillon‐Bentata, Michaël Joubert, Tadej Battelino, Emmanuel Cosson, Fleur Levrat‐Guillen, Jochen Seufert, Gérard de Pouvourville, Ramzi Ajjan, Éric Vicaut
article en
1 citations

Abstract

The study data-collection protocol is approved by the French National Commission for Informatics and Liberties, including approval from the <i>Comité Ethique et Scientifique pour les Recherches, les Etudes et les Evaluations dans le domaine de la Santé</i>. This study complies with French and European regulations, including those relating to the General Data Protection Regulation. This study uses pseudonymous information, not requiring informed consent. Dissemination plans include full publication of the study outcomes in peer-reviewed journal(s) with open access and presentations at national and international diabetes and cardiovascular conferences.

BMJ OpenVol. 15(1)
Conservatoire National des Arts et Métiers (FR), École Supérieure des Sciences Économiques et Commerciales (FR), University of Leeds (GB), Université de Bordeaux (FR), Inserm (FR), University of Freiburg (DE), Ljubljana University Medical Centre (SI), Abbott (United Kingdom) (GB), Université Sorbonne Paris Nord (FR), CY Cergy Paris Université (FR), Equipe de Recherche en Epidémiologie Nutritionnelle (FR), Université de Caen Normandie (FR)
Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Intarcia Therapeutics, Insulet Corporation, Dexcom, European Commission, Novo Nordisk, Javna Agencija za Raziskovalno Dejavnost RS, Servier, Ipsen, National Institutes of Health, Abbott Diabetes Care
Good health and well-being
Openalex Percentile: Top 24%
Diabetes Management and Research
1.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.